YOUR HEALTH. A MORE INFORMED VIEW.
A stool-based molecular panel with its published pathogen groups and target names made visible.
CLINICAL AUTHORDr Nirupama SabhapathySpecialist Clinical Pathology
THE PURPOSE BEHIND THE PANEL.
This view contains bacterial, viral and parasitic targets, including groups containing several genogroups or species. A clinician interprets detection with diarrhoea or other symptoms, recent travel, medicines and the specimen history. The panel is for defined infectious targets, not every cause of digestive symptoms.
5named targets5 listed entries
This view contains 5 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
A positive molecular result does not always establish the cause of symptoms, and the panel does not assess all inflammatory, functional or dietary conditions.
4named targets4 listed entries
This view contains 4 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
A positive molecular result does not always establish the cause of symptoms, and the panel does not assess all inflammatory, functional or dietary conditions.
12named targets12 listed entries
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
A positive molecular result does not always establish the cause of symptoms, and the panel does not assess all inflammatory, functional or dietary conditions.
KNOW EXACTLY WHAT YOU ARE CHOOSING.
The laboratory publishes 28 targets across 21 displayed source rows. Some rows combine viral genogroups, bacterial species or toxin targets. The original grouped wording is retained rather than inventing separate assays.
21 named target entries · 28 Pathogens
This view contains 5 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 4 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 4 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 4 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 4 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Try a test or target name, or choose another health focus.
Checking a prescription?
Let’s make sure it matches.
THE RIGHT START DEPENDS ON YOU.
Choose the investigation around the question you want to discuss. A positive molecular result does not always establish the cause of symptoms, and the panel does not assess all inflammatory, functional or dietary conditions.
This view contains bacterial, viral and parasitic targets, including groups containing several genogroups or species. A clinician interprets detection with diarrhoea or other symptoms, recent travel, medicines and the specimen history. The panel is for defined infectious targets, not every cause of digestive symptoms.
Compare the full included list with your clinician’s request. A positive molecular result does not always establish the cause of symptoms, and the panel does not assess all inflammatory, functional or dietary conditions.
Bring earlier results and the relevant symptom or treatment history. The clinician can decide whether this scope, a smaller test selection or a different investigation is the most useful next step.
MAKE THE SAMPLE COUNT.
Preparation follows the actual specimen and tests in Gastro Intestine Advanced. Confirm your personal instructions before collection.
A personal checklist. Your care team confirms the instructions.
YOUR COLLECTION. YOUR CHOICE.
Both routes lead to the same defined package. Choose the location during checkout; this package waives the collection fee for its visit.
YOUR PLACE. THE SAME LABORATORY PATHWAY.
Discuss collection at your home, hotel or workplace in Dubai. The care team confirms the appropriate specimen, preparation and collection arrangements for this package.
Across DubaiTHE LABORATORY. READY TO WELCOME YOU.
Intel Lab · Deira
101–102, Al Hawai Building, Al Rigga Road, Al Muraqqabat, Deira, Dubai
DEIRA · DUBAI101–102Al Hawai Building
Al Rigga Road
FROM BOOKING TO UNDERSTANDING.
Follow Gastro Intestine Advanced from your care bag to an informed conversation.
The right package. The right person.
Add Gastro Intestine Advanced to your care bag. Book for yourself or assign the package to someone else. The care team can help match the selection to a request or prescription.
Preparation follows the test.
Confirm the instructions for stool and the appropriate collection arrangements. Correct identification, specimen choice and timing support a useful result.
Laboratory work, behind the finding.
Intel Lab processes the sample and checks the report. The package lists 72 hours; collection timing and any additional laboratory checks may affect release.
A finding, placed in your context.
Read the report with the reason for testing. A clinician can explain unexpected findings, relevant limitations and whether any further assessment is appropriate.
MORE THAN A LIST OF NUMBERS.
Your report brings the measurements together. Explore the findings below to see which questions make the report more meaningful.
UNDERSTANDING YOUR REPORTStool
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 5 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. A positive molecular result does not always establish the cause of symptoms, and the panel does not assess all inflammatory, functional or dietary conditions.
UNDERSTANDING YOUR REPORTStool
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 4 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. A positive molecular result does not always establish the cause of symptoms, and the panel does not assess all inflammatory, functional or dietary conditions.
UNDERSTANDING YOUR REPORTStool
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 12 grouped entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. A positive molecular result does not always establish the cause of symptoms, and the panel does not assess all inflammatory, functional or dietary conditions.
THE NEXT STEP IS PERSONAL.
Connect the laboratory findings with the reason for this specific test. A report supports the next clinical conversation; it does not decide it for you.
Discuss any detected target with the symptom history, medicines and relevant travel or exposure. Clinical review determines whether the finding explains the illness and whether other investigations are needed.
Discuss this result with a clinician who knows the reason for testing. Further investigations or follow-up depend on the actual findings and your circumstances.
THE LABORATORY BEHIND YOUR RESULTS.
Intelligent Care brings the collection to you. Intel Lab brings the laboratory pathway, from sample handling to reporting.
Accurate patient details, the correct specimen and clear collection instructions are the first part of a reliable laboratory pathway. Follow the collection team’s instructions for the specimens required by this panel.
The laboratory’s analytical work and quality processes support the measurements in the report. Explore the laboratory’s published quality standards and accreditation scope for the detail behind its services.
Reporting connects the laboratory findings with their clinical use. Unexpected or significant results may need additional checks or communication with the referring clinician.
EXPERTISE WITH A NAME.
Laboratory content belongs with laboratory expertise. Explore the clinical profiles and their Dubai Health Authority directory records.
Clinical author
Laboratory Director · Intel Lab
Dr Nirupama Sabhapathy is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her published Intel Lab profile describes more than 25 years in medicine and her role as Laboratory Director.
Clinical reviewer
Specialist Clinical Pathology · Intel Lab
Dr Joyce Jose is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her public professional record includes pathology practice in the UAE and earlier experience as a professor at Gulf Medical University.
CHOOSE BY PURPOSE, NOT JUST COUNT.
Related packages may ask different questions. Compare their actual scope and discuss which, if any, is appropriate for you.
You are viewingA comprehensive 28-target stool PCR panel spanning gastrointestinal viruses, bacteria and parasites: from norovirus and rotavirus to Salmonella, E.…
Blood testing for specific IgE with a 30-entry food panel. Results support assessment of suspected food allergy and need interpretation with symptoms and clinical history.
Blood count, liver, kidney, cholesterol, blood sugar and urine tests: the essentials in one visit.
A broad whole-body screen covering blood, urine and stool with kidney, liver, lipid, iron, diabetes and vitamin markers.
Choosing for a particular need?
We can help you read the options.
BEFORE YOU BOOK.
Preparation, sample types, timing and what the package does—and does not—include.
A stool-based molecular panel with its published pathogen groups and target names made visible. The full named inventory on this page is the scope of the package.
Several source rows group multiple genogroups, species or toxin targets. The full source wording is shown so the published 28-target claim is not confused with 28 separate purchasable tests.
No. It is a defined infectious-target panel, not a measurement of general gut health or food tolerance.
No. Molecular detection needs the clinical context, including symptoms, medicines and possible carriage.
No. Other questions may require different stool tests, blood tests, imaging or examination.
Keep the specimen separate from urine and toilet water, following the collection instructions supplied by the team.
Yes. Choose home collection across Dubai or a visit to Intel Lab in Deira. Any health package waives the collection fee for its own visit; separate appointments are assessed separately.
The package price is AED 699; the listed turnaround is 72 hours. Confirm collection and processing arrangements with the team. Turnaround is not a guarantee that every result will be released at one exact time.
Review relevant findings with a qualified clinician alongside the reason for testing, symptoms, medicines and prior results. The report may lead to reassurance about the tested question, confirmation, a targeted investigation or follow-up—not an automatic treatment decision.
YOUR NEXT STEP. AROUND YOU.
Gastro Intestine Advanced · 28 Pathogens · Stool